Ticker: ITRM

Iterum Therapeutics plc (NASDAQ: ITRM) has recently released its quarterly financial report for the period ended March 31, 2025. Below are the key points and statistics concerning its income statement, as well as notable positive and negative aspects impacting the company. Positive Aspects: Net ...